Company
Ikano Therapeutics, Inc.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Ikano Therapeutics, Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative nasally delivered pharmaceutical products, with a particular focus on drugs treating pain and disorders related to the central nervous system. Several products are in Phase II human studies including Midazolam for epilepsy patients.
Loading relationship preview